OVERVIEW
The market for insulin delivery devices is expected to reach USD 22.5 billion by 2024, rising over the forecast period at a CAGR of 8.12%. The major drivers on the market include favorable reimbursement scenario and government support in selected countries, developments in insulin delivery systems technology, and increasing diabetic population.
TABLE OF CONTENT
1 Global Insulin Delivery Devices Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Insulin Delivery Devices Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Insulin Delivery Devices Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Insulin Delivery Devices Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Insulin Delivery Devices Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Insulin Delivery Devices Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Insulin Delivery Devices Market – By Component (Market Size – & million/billion)
8.1 Pens
8.2 Pumps
8.3 Pen Needles
8.4 Syringes
8.5 Other
9 Global Insulin Delivery Devices Market – By End-User
9.1 Patients/Homecare
9.2 Hospitals & Clinics
10 Global Insulin Delivery Devices Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Insulin Delivery Devices Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Insulin Delivery Devices Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Becton, Dickinson and Company
12.3 Novo Nordisk A/S
12.4 Medtronic PLC
12.5 Animas Corporation (Johnson and Johnson)
12.6 Tandem Diabetes Care, Inc.
12.7 Sanofi
12.8 Insulet Corporation
12.9 ELI Lilly and Company
12.10 Ypsomed Holding AG
12.11 Biocon Limited
12.12 Company 11 & more
13 Global Insulin Delivery Devices Market – Appendix
13.1 Sources
13.2 Abbreviations